Kuo‐Cheng Lu

5.9k total citations
210 papers, 4.1k citations indexed

About

Kuo‐Cheng Lu is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Kuo‐Cheng Lu has authored 210 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Nephrology, 31 papers in Molecular Biology and 30 papers in Pathology and Forensic Medicine. Recurrent topics in Kuo‐Cheng Lu's work include Parathyroid Disorders and Treatments (45 papers), Dialysis and Renal Disease Management (31 papers) and Vitamin D Research Studies (27 papers). Kuo‐Cheng Lu is often cited by papers focused on Parathyroid Disorders and Treatments (45 papers), Dialysis and Renal Disease Management (31 papers) and Vitamin D Research Studies (27 papers). Kuo‐Cheng Lu collaborates with scholars based in Taiwan, United States and Japan. Kuo‐Cheng Lu's co-authors include Chia‐Chao Wu, Cai‐Mei Zheng, Min-Tser Liao, Yuh‐Feng Lin, Yi‐Chou Hou, Wen-Chih Liu, Chien‐Lin Lu, Shih‐Hua Lin, Pauling Chu and Chih‐Chien Sung and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kuo‐Cheng Lu

196 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuo‐Cheng Lu Taiwan 35 1.3k 842 660 513 473 210 4.1k
Chia‐Chao Wu Taiwan 33 963 0.7× 806 1.0× 509 0.8× 386 0.8× 425 0.9× 154 3.3k
Muhammad M. Yaqoob United Kingdom 36 1.6k 1.2× 1.2k 1.4× 476 0.7× 774 1.5× 561 1.2× 132 4.6k
Chih‐Kang Chiang Taiwan 42 1.5k 1.1× 1.2k 1.4× 313 0.5× 617 1.2× 551 1.2× 177 5.0k
Robert G. Fassett Australia 34 1.4k 1.0× 1.1k 1.3× 255 0.4× 641 1.2× 721 1.5× 140 4.6k
Toshiki Moriyama Japan 43 2.0k 1.5× 1.3k 1.5× 517 0.8× 556 1.1× 738 1.6× 220 5.5k
Carmelinda Ruggiero Italy 39 606 0.5× 789 0.9× 454 0.7× 1.0k 2.0× 612 1.3× 120 4.9k
Chien‐Te Lee Taiwan 35 801 0.6× 701 0.8× 175 0.3× 433 0.8× 388 0.8× 173 3.4k
Vassilios Liakopoulos Greece 40 2.4k 1.8× 1.0k 1.2× 376 0.6× 591 1.2× 1.0k 2.2× 382 6.6k
Emil Hagström Sweden 37 745 0.6× 477 0.6× 686 1.0× 653 1.3× 824 1.7× 119 4.1k
Jerzy Chudek Poland 34 680 0.5× 972 1.2× 414 0.6× 1.0k 2.0× 705 1.5× 410 5.4k

Countries citing papers authored by Kuo‐Cheng Lu

Since Specialization
Citations

This map shows the geographic impact of Kuo‐Cheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo‐Cheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo‐Cheng Lu more than expected).

Fields of papers citing papers by Kuo‐Cheng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuo‐Cheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo‐Cheng Lu. The network helps show where Kuo‐Cheng Lu may publish in the future.

Co-authorship network of co-authors of Kuo‐Cheng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Kuo‐Cheng Lu. A scholar is included among the top collaborators of Kuo‐Cheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuo‐Cheng Lu. Kuo‐Cheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Ching‐Liang, et al.. (2025). Risk of hematologic malignancies following herpes zoster after COVID-19: a global cohort study. Frontiers in Medicine. 12. 1651614–1651614.
3.
Lu, Kuo‐Cheng, et al.. (2024). Types of cell death and their relations to host immunological pathways. Aging. 16(15). 11755–11768. 6 indexed citations
4.
Zheng, Cai‐Mei, Yi‐Chou Hou, Kuo‐Wang Tsai, et al.. (2024). Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways. International Journal of Medical Sciences. 21(13). 2437–2449. 4 indexed citations
5.
Zheng, Cai‐Mei, Min-Tser Liao, & Kuo‐Cheng Lu. (2024). #1921 Resveratrol improves the indoxyl sulfate-induced intestinal damage by promoting mitophagy and inhibiting apoptosis pathways. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations
6.
Hou, Yi‐Chou, Min-Tser Liao, Kuo‐Wang Tsai, et al.. (2023). Indoxyl sulfate induced frailty in patients with end-stage renal disease by disrupting the PGC-1α–FNDC5 axis. Aging. 15(20). 11532–11545. 2 indexed citations
8.
Wu, Chia‐Lin, Yu‐Wei Fang, Yi‐Chou Hou, et al.. (2023). Association of mono-2-ethylhexyl phthalate with adverse outcomes in chronic hemodialysis patients. Environmental Science and Pollution Research. 30(57). 120366–120374. 2 indexed citations
9.
Lin, Chia-Wei, Yuh‐Feng Lin, Kuo‐Cheng Lu, et al.. (2023). Influenza vaccination is associated with lower risk of renal cell carcinoma among chronic kidney disease patients: a population-based cohort study. Clinical Kidney Journal. 16(11). 1936–1946.
10.
Hou, Yi‐Chou, Cai‐Mei Zheng, Hui‐Wen Chiu, et al.. (2022). Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease. Pharmaceuticals. 15(8). 952–952. 13 indexed citations
12.
Chou, Yu‐Ching, et al.. (2021). Biomarkers Linked with Dynamic Changes of Renal Function in Asymptomatic and Mildly Symptomatic COVID-19 Patients. Journal of Personalized Medicine. 11(5). 432–432. 10 indexed citations
13.
Liao, Min-Tser, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, et al.. (2021). Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients. Antioxidants. 10(9). 1440–1440. 33 indexed citations
14.
Huang, Yen‐Sung, Kuo‐Cheng Lu, Hsu‐Wen Chao, et al.. (2020). The MTNR1A mRNA is stabilized by the cytoplasmic hnRNPL in renal tubular cells. Journal of Cellular Physiology. 236(3). 2023–2035. 5 indexed citations
15.
Liu, Wen-Chih, Jia-Fwu Shyu, Yuh‐Feng Lin, et al.. (2020). Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway. International Journal of Molecular Sciences. 21(20). 7483–7483. 30 indexed citations
16.
Lu, Chien‐Lin, Kuo-Chin Hung, Pei‐Chen Wu, et al.. (2019). The Paradoxical Role of Uric Acid in Osteoporosis. Nutrients. 11(9). 2111–2111. 91 indexed citations
17.
Zheng, Cai‐Mei, Yung-Ho Hsu, Chia‐Chao Wu, et al.. (2019). Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease. International Journal of Molecular Sciences. 20(11). 2800–2800. 11 indexed citations
19.
Huang, Yen‐Sung, Kuo‐Cheng Lu, Tai‐Kuang Chao, et al.. (2018). Role of melatonin receptor 1A and pituitary homeobox‐1 coexpression in protecting tubular epithelial cells in membranous nephropathy. Journal of Pineal Research. 65(1). e12482–e12482. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026